Maternal substance use during pregnancy and associated factors in Adama, central Ethiopia.

IF 2.3 Q2 OBSTETRICS & GYNECOLOGY Frontiers in global women's health Pub Date : 2025-02-27 eCollection Date: 2025-01-01 DOI:10.3389/fgwh.2025.1540814
Kimiya Mohammed, Mihiret Shawel Getahun, Yohanes Abera Belachwe, Nesra Mohammed Fati, Yohannes Mekuria Negussie
{"title":"Maternal substance use during pregnancy and associated factors in Adama, central Ethiopia.","authors":"Kimiya Mohammed, Mihiret Shawel Getahun, Yohanes Abera Belachwe, Nesra Mohammed Fati, Yohannes Mekuria Negussie","doi":"10.3389/fgwh.2025.1540814","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Substance use, including tobacco, alcohol, khat, and illicit drugs, is a significant preventable contributor to the global burden of disease. Women are particularly vulnerable during their reproductive years, with substance use during pregnancy posing serious risks to maternal and fetal health. Therefore, this study aimed to assess of prevalence of substance use and determine associated risk factors among pregnant women in Adama, Central Ethiopia.</p><p><strong>Methods: </strong>A health facility-based cross-sectional study was conducted among 472 pregnant women. Participants were selected using a systematic sampling technique. Data were collected through an interviewer-administered structured questionnaire. Binary logistic regression was employed to model the association between substance use and explanatory variables. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were used to estimate the strength of association. Statistical significance was determined at a <i>p</i>-value < 0.05.</p><p><strong>Result: </strong>The overall prevalence of substance use during pregnancy was 22.0% (95% CI: 18.2-26.0). Unplanned pregnancy (AOR = 3.49, 95% CI: 1.23-9.89), pre-pregnancy substance use (AOR = 24.16, 95% CI: 11.49-40.82), husband/partner substance use (AOR = 4.51, 95% CI: 1.44-14.20), and ever heard about the side effects of substance use (AOR = 14.60, 95% CI: 5.31-17.65) were factors significantly associated with maternal substance use during pregnancy.</p><p><strong>Conclusion: </strong>Nearly one in four pregnant women reported using substances during pregnancy. Educational and counseling interventions during antenatal care should emphasize the risks of substance use on maternal health and fetal development, particularly targeting women with a history of substance use or unplanned pregnancies. Efforts should also involve partners and employ community-based strategies to raise awareness of these risks.</p>","PeriodicalId":73087,"journal":{"name":"Frontiers in global women's health","volume":"6 ","pages":"1540814"},"PeriodicalIF":2.3000,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11903442/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in global women's health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fgwh.2025.1540814","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Substance use, including tobacco, alcohol, khat, and illicit drugs, is a significant preventable contributor to the global burden of disease. Women are particularly vulnerable during their reproductive years, with substance use during pregnancy posing serious risks to maternal and fetal health. Therefore, this study aimed to assess of prevalence of substance use and determine associated risk factors among pregnant women in Adama, Central Ethiopia.

Methods: A health facility-based cross-sectional study was conducted among 472 pregnant women. Participants were selected using a systematic sampling technique. Data were collected through an interviewer-administered structured questionnaire. Binary logistic regression was employed to model the association between substance use and explanatory variables. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were used to estimate the strength of association. Statistical significance was determined at a p-value < 0.05.

Result: The overall prevalence of substance use during pregnancy was 22.0% (95% CI: 18.2-26.0). Unplanned pregnancy (AOR = 3.49, 95% CI: 1.23-9.89), pre-pregnancy substance use (AOR = 24.16, 95% CI: 11.49-40.82), husband/partner substance use (AOR = 4.51, 95% CI: 1.44-14.20), and ever heard about the side effects of substance use (AOR = 14.60, 95% CI: 5.31-17.65) were factors significantly associated with maternal substance use during pregnancy.

Conclusion: Nearly one in four pregnant women reported using substances during pregnancy. Educational and counseling interventions during antenatal care should emphasize the risks of substance use on maternal health and fetal development, particularly targeting women with a history of substance use or unplanned pregnancies. Efforts should also involve partners and employ community-based strategies to raise awareness of these risks.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
埃塞俄比亚中部阿达马地区孕产妇在怀孕期间使用药物的情况及相关因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
0
审稿时长
13 weeks
期刊最新文献
Establishment of a predictive model for spontaneous preterm birth in primiparas with grade A1 gestational diabetes mellitus. Global burden, trends and inequalities of maternal hypertensive disorders among reproductive-age women of advanced maternal age, 1990-2021: a population-based study. Perspectives of women from migrant and refugee backgrounds accessing the Cross Cultural Worker Service in maternity and early childhood services-a qualitative study. An exploration of sub-national variability in institutional maternal mortality ratios in Kenya: a meta-analysis of the 2021 health facility data. Analysis of risk factors for depression and anxiety in women with polycystic ovary syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1